Flupirtine Determination in Human Blood Plasma by HPLC with Mass-Spectrometric Detection and its Application to Pharmacokinetic Studies
- 作者: Krasnykh L.M.1, Rodina T.A.1, Mel’nikov E.S.2, Vasilenko G.F.1, Smirnov V.V.1,2, Sokolov A.V.1,2, Arkhipov V.V.1,2
-
隶属关系:
- Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation
- I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)
- 期: 卷 51, 编号 12 (2018)
- 页面: 1123-1128
- 栏目: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/244942
- DOI: https://doi.org/10.1007/s11094-018-1752-2
- ID: 244942
如何引用文章
详细
A validated method for quantitative determination of flupirtine in human blood plasma using liquid chromatography combined with tandem mass spectrometry (HPLC-MS/MS) was proposed. Biological samples were prepared by precipitating proteins using MeOH. The chromatographic separation used a Zorbax Eclipse Plus C18 column with gradient elution. A Shimadzu 8040 triple quadrupole mass spectrometer in multiple-reaction-monitoring mode (+MRM) with chemical ionization at atmospheric pressure (APCI) was used to determine the molecular ion of flupirtine with m/z 305.2. Acalibration curve for flupirtine was linear (R = 0.994) in the concentration range 25 – 2,500 ng/mL with a lower detection limit of 25 ng/mL. Validation of the method indicated that it was highly sensitive, specific, accurate, and precise and that the analyte was stable. The method was successfully applied to comparative pharmacokinetic studies of drugs containing flupirtine.
作者简介
L. Krasnykh
Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation
编辑信件的主要联系方式.
Email: lkrasnykhLM59@mail.ru
俄罗斯联邦, 8/2 Petrovskii Blvd., Moscow, 127051
T. Rodina
Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation
Email: lkrasnykhLM59@mail.ru
俄罗斯联邦, 8/2 Petrovskii Blvd., Moscow, 127051
E. Mel’nikov
I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)
Email: lkrasnykhLM59@mail.ru
俄罗斯联邦, 8/2 Trubetskaya St., Moscow, 119991
G. Vasilenko
Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation
Email: lkrasnykhLM59@mail.ru
俄罗斯联邦, 8/2 Petrovskii Blvd., Moscow, 127051
V. Smirnov
Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation; I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)
Email: lkrasnykhLM59@mail.ru
俄罗斯联邦, 8/2 Petrovskii Blvd., Moscow, 127051; 8/2 Trubetskaya St., Moscow, 119991
A. Sokolov
Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation; I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)
Email: lkrasnykhLM59@mail.ru
俄罗斯联邦, 8/2 Petrovskii Blvd., Moscow, 127051; 8/2 Trubetskaya St., Moscow, 119991
V. Arkhipov
Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation; I. M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University)
Email: lkrasnykhLM59@mail.ru
俄罗斯联邦, 8/2 Petrovskii Blvd., Moscow, 127051; 8/2 Trubetskaya St., Moscow, 119991
补充文件
